Abeona Therapeutics Inc. (0H7R.L) LSE

5.58

-0.1262(-2.21%)

Updated at June 02 04:24PM

Currency In USD

Valuation

Market Cap283.83M
Enterprise Value230.36M
P/E Ratio4.87
PEG Ratio0.02
Price/Sales Ratio22.3
Price/Book Ratio2.22
Enterprise/Revenue19.68
Enterprise/EBITDA4.29

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin4.55
Operating Margin-6.38

Management Effectiveness

Return On Assets0.33
Return On Equity0.41

Income Statement

Revenue5.82M
Revenue/Share0.26
Gross Profit-1.17M
EBITDA-85.89M
Net Income71.18M
Diluted EPS1.01

Balance Sheet

Total Cash168.27M
Total Cash/Share2.97
Total Debt23.17M
Total Debt/Equity0.16
Current Ratio5.89
Book Value Per Share2.56

Price History

52-Week Change-12.26
52-Week High8.8
52-Week Low2.35
Moving Average 50 Days6.1
Moving Average 200 Days4.53

Statistics

Average Volume1,007
Shares Outstanding47.94M
% Held by Institutions74.66

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateJuly 05, 2022